Drugs for Diastolic Heart Failure (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 123)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Sodium citrate |
Approved, Investigational |
Phase 4 |
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
2 |
|
Sildenafil |
Approved, Investigational |
Phase 4 |
|
139755-83-2, 171599-83-0 |
5212 135398744 |
Synonyms:
1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine
1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulphonyl)-4-methylpiperazine
1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate
1-{[3-(4,7-DIHYDRO-1-METHYL-7-OXO-3-PROPYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-5-YL)-4-ETHOXYPHENYL]SULFONYL}-4-METHYLPIPERAZINE
5-[2-ETHOXY-5-(4-METHYLPIPERAZIN-1-YLSULFONYL)PHENYL]-1-METHYL-3-PROPYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-7(6H)-ONE
5-[2-ETHOXY-5-(4-METHYL-PIPERAZINE-1-SULFONYL)-PHENYL]-1-METHYL-3-PROPYL-1,6-DIHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-7-ONE
Acetildenafil
Aphrodil
Caverta
Citrate, sildenafil
Desmethyl sildenafil
Desmethylsildenafil
HIP0908
HIP-0908
Homosildenafil
Hydroxyhomosildenafil
Lactate, sildenafil
NCX 911
|
NCX-911
NIPATRA
Nitrate, sildenafil
Revatio
Sildenafil
Sildenafil citrate
Sildenafil lactate
Sildenafil nitrate
Sildenafil Viagra
Sildenafil, desmethyl
Sildenafilo
UK-92480
UK-9248010
UK-92480-10
Viagra
Viagra®
VIZARSIN
|
|
3 |
|
Spironolactone |
Approved |
Phase 4 |
|
1952-01-7, 52-01-7 |
5833 |
Synonyms:
ABBOLACTONE
Acelat
Aldace
Aldactazide
Aldactide
Aldactone
Aldactone a
Aldactone®|spiractin|spirotone
Alderon
Aldopur
Almatol
Alphapharm brand OF spironolactone
Alpharma brand OF spironolactone
Alter brand OF spironolactone
Altex
Aquareduct
Ashbourne brand OF spironolactone
Azupharma brand OF spironolactone
Betapharm brand OF spironolactone
Cardel brand OF spironolactone
CAROSPIR
CT Arzneimittel brand OF spironolactone
CT, Spiro von
CT-Arzneimittel brand OF spironolactone
Deverol
Dexo brand OF spironolactone
DIATENSEC
Dira
Duraspiron
Espironolactona
Espironolactona [INN-Spanish]
Espironolactona alter
Espironolactona mundogen
Euteberol
Flumach
Frumikal
Generosan brand OF spironolactone
GX SPIRONOL
Hormosan brand OF spironolactone
Jenapharm brand OF spironolactone
Jenaspiron
Lacalmin
Lacdene
LARACTONE
Mayoly-spindler brand OF spironolactone
Melarcon
Merck dura brand OF spironolactone
Mundogen brand OF spironolactone
Nefurofan
Novo spiroton
Novopharm brand OF spironolactone
Novo-spiroton
NovoSpiroton
NSC-150399
Osyrol
Pfizer brand OF spironolactone
|
Pharmafrid brand OF spironolactone
Practon
Roche brand OF spironolactone
Sagisal
SC-9420
Searle brand OF spironolactone
Sincomen
SNL
Spiractin
Spiresis
SPIRETIC
Spiridon
SPIRNOLACTONE
Spiro l.u.t.
Spiro von CT
Spirobeta
Spiroctan
SPIROCTAN 100
SPIROCTAN 25
SPIROCTAN 50
Spiroctanie
Spiroderm
Spirogamma
Spirolactone
Spirolakton
Spirolang
Spirolone
Spirone
Spirono isis
Spironocompren
Spirono-isis
SPIRONOLACTONE
Spironolactone [BAN:INN:JAN]
Spironolactone A
Spironolactonum
Spironolactonum [INN-Latin]
Spironolattone
Spironolattone [DCIT]
Spironone
Spirospare
SPIROSPARE 100
SPIROSPARE 25
Spiro-Tablinen
SPIROTONE
Sprioderm
Supra-puren
Suracton
Uractone
Urusonin
Veroshpiron
Verospiron
Verospirone
Verospirone Opianin
Von CT, spiro
Wörwag brand OF spironolactone
Xenalon
|
|
4 |
|
Valsartan |
Approved, Investigational |
Phase 4 |
|
137862-53-4 |
60846 |
Synonyms:
(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
CGP-48933
CGP-48933|Diovan®|Prexxartan® (oral solution)
Diovan
EXFORGE
Kalpress
Miten
N-(p-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
Nisis
|
N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-Valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
PREXXARTAN
Provas
Tareg
VAL489
Vals
VALSARTAN
|
|
5 |
|
Angiotensin II |
Approved, Investigational |
Phase 4 |
|
68521-88-0, 11128-99-7, 4474-91-3 |
172198 |
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
5 L Isoleucine angiotensin II
5-Isoleucine-angiotensin II
5-L-Isoleucine angiotensin II
5-L-Isoleucineangiotensin II
Ang II
ANG-(1-8)octapeptide
Angiotensin
Angiotensin 2
Angiotensin II
Angiotensin II (human)
Angiotensin II (mouse)
Angiotensin II, 5-L-isoleucine
Angiotensin-(1-8) octapeptide
Angiotonin
|
Asp-arg-val-tyr-ile-his-pro-phe
Delivert
Human angiotensin II
Hypertensin
II, 5-L-isoleucine angiotensin
Ile(5)-angiotensin II
Ile5-angiotensin II
Isoleucine(5)-angiotensin
Isoleucine(5)-angiotensin II
isoleucine5-angiotensin II
Isoleucyl(5)-angiotensin II
N-(1-(N-(N-(N-(N-(N(2)-L-a-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-alpha-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-Α-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
Valyl(5)-angiotensin II
|
|
6 |
|
Regadenoson |
Approved, Investigational |
Phase 4 |
|
313348-27-5 |
22451303 219024 |
Synonyms:
1-{6-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-2-yl}-N-methyl-1H-pyrazole-4-carboximidate
CVT-3146
CVT-3146|Lexiscan®|Rapiscan®
|
Lexiscan
REGADENOSON
Regadenoson anhydrous
|
|
7 |
|
Adenosine |
Approved, Investigational |
Phase 4 |
|
58-61-7 |
60961 |
Synonyms:
(2R,3R,4R,5R)-2-(6-AMINOPURIN-9-YL)-5-(HYDROXYMETHYL)OXOLANE-3,4-DIOL
(2R,3R,4R,5R)-2-(6-AMINOPURIN-9-YL)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL
(2R,3R,4R,5R)-2-(6-AMINOPURIN-9-YL)-5-METHYLOL-TETRAHYDROFURAN-3,4-DIOL
(2R,3R,4S,5R)-2-(6-AMINO-9H-PURIN-9-YL)-5-(HYDROXYMETHYL)OXOLANE-3,4-DIOL
(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-delta-ribofuranose
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-D-ribofuranose
6-Amino-9-b-D-ribofuranosyl-9H-purine
6-Amino-9beta-delta-ribofuranosyl-9H-purine
6-Amino-9beta-D-ribofuranosyl-9H-purine
6-Amino-9-beta-D-ribofuranosyl-9H-purine
6-Amino-9-β-D-ribofuranosyl-9H-purine
9-b-D-Ribofuranosidoadenine
9-b-D-Ribofuranosyl-9H-purin-6-amine
9-beta-D-Arabinofuranosyladenine
9-beta-delta-Arabinofuranosyladenine
9-beta-delta-Ribofuranosidoadenine
9beta-delta-Ribofuranosyl-9H-purin-6-amine
9-beta-delta-Ribofuranosyl-9H-purin-6-amine
9beta-delta-Ribofuranosyladenine
9-beta-delta-Ribofuranosyladenine
9-beta-D-Ribofuranosidoadenine
9beta-D-Ribofuranosyl-9H-purin-6-amine
9-beta-D-Ribofuranosyl-9H-purin-6-amine
9beta-D-Ribofuranosyladenine
9-beta-D-Ribofuranosyladenine
9-Î’-D-ribofuranosidoadenine
9-Î’-D-ribofuranosyl-9H-purin-6-amine
ADENIN RIBOSIDE
Adenine deoxyribonucleoside
|
Adenine nucleoside
Adenine riboside
Adenine-9beta-delta-ribofuranoside
Adenine-9beta-D-ribofuranoside
Adenocard
Adenocard®|Adenoscan®
Adenocor
ADENOGESIC
Adenoscan
Adenosin
ADENOSINA
ADENOSINE
ADÉNOSINE
ADENOSINUM
Adenyldeoxyriboside
Ade-rib
Ado
b-D-Adenosine
beta-Adenosine
beta-D-Adenosine
beta-delta-Adenosine
Boniton
Deoxyadenosine
Desoxyadenosine
Myocol
NSC-7652
Nucleocardyl
Sandesin
SR-96225
Î’-D-adenosine
|
|
8 |
|
Dopamine |
Approved |
Phase 4 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
9 |
|
Furosemide |
Approved, Vet_approved |
Phase 4 |
|
54-31-9 |
3440 |
Synonyms:
2-Furfurylamino-4-chloro-5-sulfamoylbenzoate
2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid
2-Furfurylamino-4-chloro-5-sulphamoylbenzoate
2-Furfurylamino-4-chloro-5-sulphamoylbenzoic acid
4-Chloro-5-sulfamoyl-N-furfuryl-anthranilate
4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid
4-Chloro-5-sulphamoyl-N-furfuryl-anthranilate
4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid
4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilate
4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid
4-Chloro-N-(2-furylmethyl)-5-sulphamoylanthranilate
4-Chloro-N-(2-furylmethyl)-5-sulphamoylanthranilic acid
4-Chloro-N-furfuryl-5-sulfamoylanthranilate
4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid
4-Chloro-N-furfuryl-5-sulphamoylanthranilate
4-Chloro-N-furfuryl-5-sulphamoylanthranilic acid
Acetic acid potassium salt
Aisemide
Aldalix
Aldic
Aluzine
ALUZINE 20
ALUZINE 40
ALUZINE 500
Anfuramaide
Apo-frusemide
Apo-furosemide
AQUAMED
Aquarid
Aquasin
Arasemide
Beronald
Bioretic
Bristab
Bristurin
Cetasix
Depix
Desal
Desdemin
Di-Ademil
DIHYDROFLUMETHIAZIDE
dihydroflumethiazide|frusemide|Lasix®|methforylthiazidine
Dirine
Disal
Discoid
Disemide
Diucardin
Diumide-K
Diural
Diurapid
DIURESAL
Diuretic salt
Diurin
Diurolasa
Diusemide
Diusil
Diuzol
Dranex
Dryptal
Durafurid
Edemid
Edenol
Eliur
Elodrine
Endural
Errolon
Eutensin
Farsix
Finuret
Fluidrol
Fluss
Franyl
FROOP
FRUMAX
Frumex
Frumide
Frumil
Frusedan
Frusema
Frusemid
Frusemide
Frusemin
Frusenex
Frusetic
Frusid
FRUSOL
Fulsix
Fuluvamide
Fuluvamine
Furanthril
Furanthryl
Furantral
Furantril
Furanturil
Furesis
Furetic
Furex
Furfan
Furix
Furmid
Furo-basan
Furobeta
Furocot
Furodiurol
Furodrix
Furomen
Furomex
Furomide m.d.
Furo-puren
Furorese
Furosan
Furose
Furosedon
Furosemid
Furosemida
Furosemida [INN-Spanish]
Furosemide
|
Furosemide "mita"
Furosemide monohydrochloride
Furosemide monosodium salt
Furosemidu
Furosemidu [Polish]
Furosemidum
Furosemidum [INN-Latin]
Furosemix
Furoside
Furosifar
Furosix
Furoter
Furovite
Fursemid
Fursemida
Fursemide
Fursol
Fusid
Fusidic acid
Golan
Hissuflux
Hydol
Hydrenox
Hydrex
Hydro
Hydroled
Hydro-rapid
Impugan
Jenafusid
Katlex
Kofuzon
Kolkin
Kutrix
Lasemid
Lasex
Lasiletten
Lasilix
Lasix
LASIX (TN)
LASIX RET
Lasix retard
Lasix Special
Laxur
Lazix
LB-502
Leodrine
Less diur
Liside
Logirene
Lowpston
Lowpstron
Luscek
Macasirool
Marsemide
Metflorylthiazidine
METHFORYLTHIAZIDINE
Mirfat
Mita
Moilarorin
Myrosemide
Nadis
Nelsix
Neo-renal
Nephron
Nicorol
Novosemide
NSC-269420
Octan draselny
Odemase
Odemex
Oedemex
Olmagran
Osyrol
Polysquall a
Prefemin
Profemin
Promedes
Promide
Protargen
Puresis
Radisemide
Radonna
Radouna
Retep
Rodiuran
Rontyl
Rosemide
Rosis
Rusyde
Sal diureticum
Salinex
Salix
Salix (brand OF furosemide)
Salurex
Salurid
Saluron
Seguril
Selectofur
Sigasalur
Sisuril
Spirofur
Synephron
TENKOFRUSE
Transit
Trofurit
Uremide
Uresix
Urex
Urex-m
Urian
Uridon
Uritol
Urosemide
Vergonil
Vesix
Yidoli
Zafimida
|
|
10 |
|
Ertugliflozin |
Approved, Investigational |
Phase 4 |
|
1210344-57-2 |
75075340 44814423 |
Synonyms:
ERTUGLIFLOZIN
MK-8835
MK-8835|PF-04971729|Steglatro®
PF04971729
|
PF-04971729
PF-04971729-00
STEGLATRO
|
|
11 |
|
Metoprolol |
Approved, Investigational |
Phase 4 |
|
37350-58-6, 51384-51-1 |
4171 |
Synonyms:
(+/-)-metoprolol
(RS)-Metoprolol
1-(Isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
Beatrolol
Beloc
Beloc duriles
Beloc-duriles
BelocDuriles
Betaloc
Betaloc astra
Betaloc-astra
BetalocAstra
Betalok
CGP-2175
CGP-2175C
CGP-2175C|GP-2175E|H-93/26|Lopressor®|Toprol®
CR-XL, Metoprolol
DL-Metoprolol
GP-2175E
H-93/26
Lopresor
Lopresoretic
LOPRESSIDONE
Lopressor
Lopressor HCT
|
Meijoprolol
Metohexal
METOPROLOL
Metoprolol CR XL
Metoprolol CR-XL
Metoprolol succinate
Metoprolol tartrate
Metoprololum
Metroprolol
Preblok
Prelis
Presolol
Seloken
Selopral
Selo-Zok
Seroken
Spesicor
Spesikor
Succinate, metoprolol
Tartrate, metoprolol
Toprol
Toprol XL
ToprolXL
Toprol-XL
|
|
12 |
|
Carvedilol |
Approved, Investigational |
Phase 4 |
|
72956-09-3 |
2585 |
Synonyms:
(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol
14C-Labeled carvedilol
Artist
BM 14.190
BM-14.190
BM-14190
BM-14-190
C07AG02
CARVEDILOL
Carvédilol
Carvedilol hydrochloride
Carvedilol, (-)
Carvedilol, (-)-isomer
Carvedilol, (+)
Carvedilol, (+)-isomer
Carvedilol, (+-)-isomer
Carvedilol, (R)-isomer
Carvedilol, (S)-isomer
Carvedilol, 14C labeled
|
Carvedilol, 14C-labeled
Carvedilolum
Carvedilolum [Latin]
Coreg
COREG CR
Coreg®|DQ 2466|Eucardic®|SKF 105517
Coropres
Dilatrend
DQ 2466
DQ-2466
Eucardic
EUCARDIC 12.5
EUCARDIC 25
EUCARDIC 3.125
EUCARDIC 6.25
Kredex
Querto
SKF 105517
SKF-105517
|
|
13 |
|
Atenolol |
Approved |
Phase 4 |
|
29122-68-7 |
2249 |
Synonyms:
1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide
Aircrit
Alinor
Altol
Anselol
Antipressan
Apo-atenolol
Atcardil
Atecard
Atehexal
ATENAMIN
Atenblock
Atendol
Atenet
Ateni
Atenil
ATENIX-100
ATENIX-25
ATENIX-50
Atenol
Atenol 1a pharma
Atenol acis
Atenol al
Atenol atid
Atenol cophar
Atenol CT
Atenol fecofar
Atenol gador
Atenol genericon
Atenol GNR
Atenol heumann
Atenol MSD
Atenol NM pharma
Atenol nordic
Atenol PB
Atenol quesada
Atenol stada
Atenol tika
Atenol trom
Atenol von CT
Atenolin
Atenol-mepha
Atenolol
ATENOLOL (JAN/USP)
ATENOLOL [USAN:BAN:INN:JAN]
Atenololum
ATENOLOLUM [INN-LATIN]
Atenol-ratiopharm
Atenol-wolff
Atenomel
Atereal
Aterol
Betablok
Betacard
Betasyn
Betatop ge
Blocotenol
Blokium
C07AB03
Cardaxen
|
Cardiopress
Corotenol
Cuxanorm
Duraatenolol
Duratenol
ESATENOLOL
Evitocor
Farnormin
Felo-bits
Hipres
Hypoten
Ibinolo
ICI 66082
ICI-66082
Internolol
Jenatenol
Juvental
KENTOL
Loten
Lo-ten
Lotenal
Myocord
Myocord®|Normiten®|Tenormin®
Normalol
Normiten
Noten
Oraday
Ormidol
Panapres
Plenacor
Premorine
Prenolol
Prenormine
Prinorm
Scheinpharm atenol
Seles beta
Selobloc
Serten
Servitenol
Stermin
Tenidon
Teno-Basan
Tenobloc
Tenoblock
Tenolol
Tenoprin
Tenoretic
Tenormin
TENORMIN 25
TENORMIN L.S.
Tenormine
TENORMINE [FRENCH]
Tensimin
TOTAMOL
Tredol
Unibloc
Uniloc
VASATEN
Vascoten
Vericordin
Wesipin
Xaten
|
|
14 |
|
Labetalol |
Approved |
Phase 4 |
|
36894-69-6 |
3869 |
Synonyms:
3-Carboxamido-4-hydroxy-a-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol
3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol
3-Carboxamido-4-hydroxy-α-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol
5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide
AH-5158A
AH-5158A FREE BASE
AH-5158A|Normodyne®|SCH-15719W|Trandate®
Albetol
Alphapharm brand OF labetalol hydrochloride
apo Labetalol
apo-Labetalol
ApoLabetalol
Apotex brand OF labetalol hydrochloride
Celltech brand OF labetalol hydrochloride
Dilevalol
faro Brand OF labetalol hydrochloride
glaxo Wellcome brand OF labetalol hydrochloride
GlaxoSmithKline brand OF labetalol hydrochloride
Hydrochloride, labetalol
Kabetalol
|
Kern brand OF labetalol hydrochloride
LABETALOL
Labétalol
Labetalol hydrochloride
Labetalol, (R,R)-isomer
Labetalolum
Labetolol
Leiras brand OF labetalol hydrochloride
Normodyne
NORMOZIDE
Presolol
R,R Labetalol
R,R-Labetalol
SCH-15719W
SCH-15719W FREE BASE
Schering brand OF labetalol hydrochloride
Shire brand OF labetalol hydrochloride
Sigma brand OF labetalol hydrochloride
Trandate
|
|
15 |
|
Acebutolol |
Approved, Investigational |
Phase 4 |
|
37517-30-9 |
1978 |
Synonyms:
(+-)-Acebutolol
(±)-ACEBUTOLOL
3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide
5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone
ACEBUTOLOL
Acebutolol gepepharm brand
Acebutolol HCL
Acebutolol heumann
Acebutolol hydrochloride
Acébutolol ratiopharm
Acebutololo
Acébutololratiopharm
Acébutolol-ratiopharm
Acebutololum
Acetobutolol
Apo acebutolol
Apo-acebutolol
ApoAcebutolol
Apotex brand OF acebutolol hydrochloride
Bayer brand OF acebutolol hydrochloride
C07AB04
DL-Acebutolol
Gepepharm brand OF acebutolol
Heumann brand OF acebutolol hydrochloride
Heumann, acebutolol
Hydrochloride, acebutolol
|
IL-17803A
IL-17803A|Sectral®
Italfarmaco brand OF acebutolol hydrochloride
Lafon ratiopharm brand OF acebutolol hydrochloride
Lafon-ratiopharm brand OF acebutolol hydrochloride
m And b 17803 a
m And b 17803a
m And b17803 a
m And b-17803 a
Monitan
N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide
N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide
Neptal
Novo acebutolol
Novo-acebutolol
NovoAcebutolol
Novopharm brand OF acebutolol hydrochloride
Prent
Proctor and gamble brand OF acebutolol hydrochloride
Rhodiapharm brand OF acebutolol hydrochloride
Rhône poulenc rorer brand OF acebutolol hydrochloride
Rhône-poulenc rorer brand OF acebutolol hydrochloride
Rhotral
Sectral
Specia brand OF acebutolol hydrochloride
Wyeth brand OF acebutolol hydrochloride
|
|
16 |
|
Betaxolol |
Approved, Investigational |
Phase 4 |
|
659-18-7, 63659-18-7 |
2369 |
Synonyms:
1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol
1-(Isopropylamino)-3-[p-(cyclopropylmethoxyethyl)phenoxy]-2-propanol
Alcon brand OF betaxolol hydrochloride
Alcon, betaxolol
Allphar brand OF betaxolol hydrochloride
ALO-140102 FREE BASE
BETAXOLOL
Bétaxolol
Betaxolol alcon
BETAXOLOL HCL
betaxolol HCl|Betoptic®|Kerlone®|SL-75212-10
Betaxolol hydrochloride
Betaxololum
Betoptic
BETOPTIC SUSP
|
Betoptima
Boots brand OF betaxolol hydrochloride
Hydrochloride, betaxolol
KERLEDEX
Kerlon
Kerlone
Lorex brand OF betaxolol hydrochloride
Oxodal
Schwarz brand OF betaxolol hydrochloride
Searle brand OF betaxolol hydrochloride
SL-75212-10
SL-7521210 FREE BASE
Synthelabo brand OF betaxolol hydrochloride
Synthélabo brand OF betaxolol hydrochloride
|
|
17 |
|
Penbutolol |
Approved, Investigational |
Phase 4 |
|
36507-48-9, 38363-40-5 |
37464 |
Synonyms:
(2S)-1-(TERT-BUTYLAMINO)-3-(2-CYCLOPENTYLPHENOXY)PROPAN-2-OL
1-(TERT-BUTYLAMINO)-3-(O-CYCLOPENTYLPHENOXY)PROPAN-2-OL
2-PROPANOL, 1-(2-CYCLOPENTYLPHENOXY)-3-((1,1-DIMETHYLETHYL)AMINO)-, (S)-
Betapressin
HOE 893
Hoe 893D
HOE-39-893D
Hoe893d
|
Hoe-893D
Levatol
PENBUTOLOL
Penbutolol sulfate
Penbutolol sulfate (2:1)
PENBUTOLOLUM
Sulfate, penbutolol
|
|
18 |
|
Sotalol |
Approved |
Phase 4 |
|
959-24-0, 3930-20-9 |
5253 |
Synonyms:
4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide
4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulphonanilide
b-Cardone
beta-Cardone
BETAPACE
BETAPACE AF
Betapace®|MJ-1999
C07AA07
Darob
Darob mite
DL-MJ-1999
Knoll pharmaceutical brand OF sotalol
|
MJ-1999
SORINE
SOTACOR
SOTALEX
SOTALOL
Sotalol HCL
Sotalol hydrochloride
Sotalol monohydrochloride
SOTALOLO
Sotalolum
SOTYLIZE
Î’-cardone
|
|
19 |
|
Bisoprolol |
Approved |
Phase 4 |
|
66722-44-9 |
2405 |
Synonyms:
(+-)-1-((a-(2-Isopropoxyethoxy)-p-tolyl)oxy)-3-(isopropylamino)-2-propanol
(+-)-1-((alpha-(2-Isopropoxyethoxy)-p-tolyl)oxy)-3-(isopropylamino)-2-propanol
(+-)-1-((Α-(2-isopropoxyethoxy)-p-tolyl)oxy)-3-(isopropylamino)-2-propanol
(RS)-1-(4-(2-Isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol
Bisoprolol
Bisoprolol fumarate
Bisoprolol fumarate (1:1) salt, (+-)-isomer
Bisoprolol fumarate (2:1) salt, (+-)-isomer
Bisoprolol fumerate
Bisoprolol hemifumarate
Bisoprolol hydrochloride
Bisoprolol methanesulfonate salt
Bisoprolol, (-)-isomer
Bisoprolol, (+-)-isomer
Bisoprolol, fumarate (1:1) salt
Bisoprolol, fumarate (2:1) salt
Bisoprololum
Cardicor
CL-297939
|
Concor
Condyline
Condylox
CONGESCOR
Detensiel
Emconcor
Emcor
EMD-33512
EMD-33-512
Euradal
Fumarate, bisoprolol
Hydrochloride, bisoprolol
Isoten
Merck brand OF bisoprolol fumarate
Monocor
Soloc
Soprol
ZEBETA
ZIAC
|
|
20 |
|
Nadolol |
Approved |
Phase 4 |
|
42200-33-9 |
39147 |
Synonyms:
Corgard
Corgard®|corzide|SQ-11725
CORZIDE
|
|
|
21 |
|
Propranolol |
Approved, Investigational |
Phase 4 |
|
318-98-9, 525-66-6 |
62882 4946 |
Synonyms:
(+-)-1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-NAPHTHYLOXY)-2-HYDROXY-3-ISOPROPYLAMINOPROPANE HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHOXY)-PROPAN-2-OL HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-ISOPROPYLAMINO-3-(1-NAPHTHOXY)-PROPAN-2-OL-HYDROCHLORIDE
Anaprilin
Anapriline
ANGILOL
APSOLOL
Avlocardyl
AY-64043
AY-64043-
BEDRANOL
BEDRANOL S.R.
Bedranol®|Hemangiol®|Inderal®|propranolol hydrochloride
Beprane
BERKOLOL
Betachron
Betadren
BETADUR CR
Betalong
Beta-Neg
BETA-PROGRANE MR
beta-Propranolol
Beta-Tablinen
Beta-Timelets
b-Propranolol
CARDINOL
Caridolol
Corpendol
Deralin
Dexpropranolol
Dl-Propranolol Hydrochloride
Dociton
DUPROMEX
Duranol
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HALF BETA-PROGRANE MR
HALF PROPANIX LA
HALF PROPATARD LA
HALF-BEPRANE CR
HALF-BETADUR CR
HALF-INDERAL LA
HEMANGEOL
Hydrochloride, propranolol
ICI-45520
Inderal
INDERAL LA
|
Inderide
INDERIDE-40/25
INDERIDE-80/25
Indobloc
INNOPRAN
INNOPRAN XL
Intermigran
Kemi S
LEDERPRONOL
LOPRANOL LA
Migrastat
NSC-91523
Obsidan
Obzidan
Oposim
Prano-Puren
PROBETA LA
Propanalol
Propanix
PROPANIX LA
PROPANIX-10
PROPANIX-160
PROPANIX-160 SR
PROPANIX-40
PROPANIX-80
Propanolol
PROPATARD LA
Prophylux
Propranalol
PROPRANOLOL
PROPRANOLOL HCL
Propranolol Hcl Intensol
Propranolol hydrochloride
PROPRANOLOL HYDROCHLORIDE INTENSOL
Propranololo
Propranololum
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
RAPRANOL SR
Rapynogen
Reducor
Reducor Line
Rexigen
SAGITTOL
Servanolol
SLO-BLOK
SLO-PRO
SLOPROLOL
Sumial
SYPROL
TESNOL
Î’-propranolol
|
|
22 |
|
Pindolol |
Approved, Investigational |
Phase 4 |
|
13523-86-9 |
4828 |
Synonyms:
1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol
1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol
1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol
4-(2-Hydroxy-3-isopropylaminopropoxy)-indole
BETADREN
Betapindol
betapindol|LB-46|Visken®
Blockin L
Blocklin L
Blocklin-L
Calvisken
Cardilate
Cardilic acid
Carvisken
|
Decreten
Durapindol
Glauco-visken
LB 46
LB-46
Pectobloc
Pinbetol
PINDOLOL
Pindololum
Prindolol
Prinodolol
Pynastin
Visken
VKN646
|
|
23 |
|
Nebivolol |
Approved, Investigational |
Phase 4 |
|
152520-56-4, 99200-09-6, 118457-14-0 |
71301 |
Synonyms:
1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol
1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol
a,Alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
alpha,Alpha'-(iminobis(methylene))bis(6-fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol
alpha,Alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
ALPHA,ALPHA'-(IMINODIMETHYLENE)BIS-(6-FLUORO-2-CHROMANMETHANOL)
Bystolic
Bystolic®|R-65824|Ro-67555
Hydrochloride, nebivolol
HYPOLOC
Lobivon
NARBIVOLOL
Nebicard-5
Nebilet
|
Nebilong
Nebipill
NEBIVOLOL
Nebivolol hydrochloride
NEBIVOLOLUM
nebivololum [latin]
Nodon
Nubeta
PI-21858
R-65824
RO-67555
Silostar
Α,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
|
|
24 |
|
Eplerenone |
Approved |
Phase 4 |
|
107724-20-9 |
443872 |
Synonyms:
9,11-Epoxy-7-(methoxycarbonyl)-3-oxo-17-pregn-4-ene-21,17-carbolactone
Eplerenon
Eplerenona
EPLERENONE
Epoxymexrenone
|
Inspra
Inspra®|SC-66110
SC-66110
SC-6611O
|
|
25 |
|
Exenatide |
Approved, Investigational |
Phase 4 |
|
141758-74-9 |
45588096 |
Synonyms:
AC 2993
AC002993
AC-002993
AC2993
AC-2993
AC2993A
AC-2993A
AC-2993LAR
BYDUREON
BYDUREON BCISE
BYDUREON PEN
|
BYETTA
DA-3091
Exenatida
EXENATIDE
EXENATIDE SYNTHETIC
Exendin 4
EXENDIN-4
ITCA-650
LY2148568
LY-2148568
SYNTHETIC EXENDIN-4
|
|
26 |
|
Glucagon |
Approved |
Phase 4 |
|
16941-32-5 |
16133228 16186314 |
Synonyms:
[<sup>125</sup>I]-glucagon
GCG(53-81)
GLUCAGEN HYPOKIT
GLUCAGON
Glucagon (recombinant dna origin)
GLUCAGON EMERGENCY KIT
|
GLUCAGON RECOMBINANT
Glucagon, human
Glucagon, porcine
GLUCAGONE
GLUCAGONUM
HSQGTFTSDYSKYLDSRRAQDFVQWLMNT
|
|
27 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
28 |
|
Phosphodiesterase Inhibitors |
|
Phase 4 |
|
|
|
29 |
|
Phosphodiesterase 5 Inhibitors |
|
Phase 4 |
|
|
|
30 |
|
Citrate |
|
Phase 4 |
|
|
|
31 |
|
Cardiotonic Agents |
|
Phase 4 |
|
|
|
32 |
|
Angiotensinogen |
|
Phase 4 |
|
|
16133225 |
Synonyms:
Hypertensinogen
Proangiotensin
Renin substrate
Renin substrate tetradecapeptide
|
Renin-substrate
Serpin a8
SERPINA8
Tetradecapeptide, renin substrate
|
|
33 |
|
Angiotensin Receptor Antagonists |
|
Phase 4 |
|
|
|
34 |
|
Angiotensin II Type 1 Receptor Blockers |
|
Phase 4 |
|
|
|
35 |
|
Giapreza |
|
Phase 4 |
|
|
|
36 |
|
Dopamine Agents |
|
Phase 4 |
|
|
|
37 |
|
Sodium Potassium Chloride Symporter Inhibitors |
|
Phase 4 |
|
|
|
38 |
|
Antioxidants |
|
Phase 4 |
|
|
|
39 |
|
Protective Agents |
|
Phase 4 |
|
|
|
40 |
|
Calcium, Dietary |
|
Phase 4 |
|
|
|
41 |
|
calcium channel blockers |
|
Phase 4 |
|
|
|
42 |
|
Sodium-Glucose Transporter 2 Inhibitors |
|
Phase 4 |
|
|
|
43 |
|
Sympathomimetics |
|
Phase 4 |
|
|
|
44 |
|
Adrenergic alpha-Antagonists |
|
Phase 4 |
|
|
|
45 |
|
Adrenergic alpha-1 Receptor Antagonists |
|
Phase 4 |
|
|
|
46 |
|
Adrenergic beta-1 Receptor Antagonists |
|
Phase 4 |
|
|
|
47 |
|
Adrenergic Antagonists |
|
Phase 4 |
|
|
|
48 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
49 |
|
Sympatholytics |
|
Phase 4 |
|
|
|
50 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 142)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Aldosterone Antagonism in Diastolic Heart Failure |
Completed |
NCT00108251 |
Phase 4 |
Eplerenone;Placebo |
2 |
A Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Determine the Effects of Valsartan on Exercise Time in Subjects With Symptomatic Diastolic Heart Failure |
Completed |
NCT00171106 |
Phase 4 |
valsartan |
3 |
Novel Treatment for Diastolic Heart Failure in Women |
Completed |
NCT00206232 |
Phase 4 |
Spironolactone |
4 |
Impacts of Aldosterone Blockade on Myocardial Remodeling in Hypertensive Patients With Diastolic Failing Heart |
Completed |
NCT01944384 |
Phase 4 |
aldactone |
5 |
Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF |
Completed |
NCT02589977 |
Phase 4 |
regadenoson |
6 |
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction (HFpEF) Patients With Acute Heart Failure and Dopamine (ROPA-DOP) Trial |
Completed |
NCT01901809 |
Phase 4 |
Furosemide;Dopamine |
7 |
A Phase 4, Single-center, Randomized, Parallel Group Study to Assess Effects of Empagliflozin on Exercise Capacity and Left Ventricular Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction and Type-2 Diabetes Mellitus |
Completed |
NCT03753087 |
Phase 4 |
Empagliflozin |
8 |
SIDAMI - Sildenafil and Diastolic Dysfunction After AMI |
Completed |
NCT01046838 |
Phase 4 |
Sildenafil;Placebo |
9 |
A Phase 4, Randomized, Open Label, Multicenter Prospective Comparative Study To Evaluate The Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure |
Recruiting |
NCT04160000 |
Phase 4 |
Rate or Rhythm control antiarrhythmic drugs for atrial fibrillation;Empiric heart failure drug therapy |
10 |
The EMMED-HF Study: Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart Failure |
Recruiting |
NCT04071626 |
Phase 4 |
Ertugliflozin 5 mg;Placebo oral tablet |
11 |
N-of-1 Trials for Deprescribing Beta-blockers in HFpEF |
Recruiting |
NCT04767061 |
Phase 4 |
Beta blockers |
12 |
N-of-1 Trials for Deprescribing Beta-blockers in HFpEF |
Recruiting |
NCT04757584 |
Phase 4 |
Beta blockers |
13 |
Echocardiographic Assessment of Pulmonary Transit Time Following Exercise |
Active, not recruiting |
NCT04336995 |
Phase 4 |
|
14 |
A Preliminary Study for the Intervention of an N-of-1 Protocol For Medication Optimization |
Not yet recruiting |
NCT05585125 |
Phase 4 |
Beta blocker |
15 |
Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure |
Terminated |
NCT02053246 |
Phase 4 |
Nebivolol |
16 |
The Use of Nesiritide in the Management of Acute Diastolic Heart Failure |
Terminated |
NCT00083772 |
Phase 4 |
Nesiritide |
17 |
Determine the Effectiveness of Eplerenone in Reversing Diastolic Dysfunction, Improving Endothelial Function, and Suppressing Natriuretic Peptides and Collagen Turnover in Patients With Diastolic Heart Failure ( PREDICT Study) |
Terminated |
NCT00293150 |
Phase 4 |
Eplerenone |
18 |
Treatment With Glucagon-Like Peptide-1 Receptor, Exenatide, in Patients With Diabetes and Heart Failure With Normal Left Ventricular Ejection Fraction |
Terminated |
NCT00799435 |
Phase 4 |
Exenatide |
19 |
Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Heart Failure With Preserved Ejection Fraction: Phase III, Randomized, Double-blind, Placebo-controlled Trial [ULTIMATE-HFpEF Trial] |
Unknown status |
NCT01599117 |
Phase 3 |
Placebo;Udenafil (Zydena) |
20 |
Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years) (OPTIMIZE-HFPEF) |
Unknown status |
NCT02425371 |
Phase 3 |
|
21 |
Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure (RELAX) |
Completed |
NCT00763867 |
Phase 3 |
Placebo;Sildenafil |
22 |
Exercise Intolerance in Elderly Diastolic Heart Failure |
Completed |
NCT00123955 |
Phase 3 |
Spironolactone;Placebo |
23 |
Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart Failure |
Completed |
NCT01411735 |
Phase 3 |
Enalapril;placebo |
24 |
Pulmonary Hypertension Secondary to Heart Failure With Preserved Systolic Function: a Target of Phosphodiesterase - 5 Inhibition in a 1- Year Duration Study |
Completed |
NCT01156636 |
Phase 2, Phase 3 |
Sildenafil;Placebo |
25 |
Endothelin Receptor Blockade in Heart Failure With Diastolic Dysfunction and Pulmonary Hypertension |
Completed |
NCT00820352 |
Phase 3 |
bosentan;placebo |
26 |
Effects of Sildenafil on Pulmonary Arterial Pressure in Patients With Heart Failure With Preserved Ejection Fraction ( HFpEF) and Pulmonary Hypertension |
Completed |
NCT01726049 |
Phase 3 |
Sildenafil;Placebo |
27 |
Impact of Empagliflozin on Functional Capacity in Heart Failure With Preserved Ejection Fraction |
Recruiting |
NCT05139472 |
Phase 3 |
Empagliflozin 10 MG |
28 |
Sympathetic Renal Denervation in Heart Failure With Normal LV Ejection Fraction: Denervation of the renAl sympathetIc nerveS in hearT Failure With nOrmal Lv Ejection Fraction |
Terminated |
NCT01583881 |
Phase 2, Phase 3 |
|
29 |
Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction. A 35-week, Single-center, Prospective, Double-blind, Controlled, Randomized, 2x2 Crossover, Interventional Phase II Study, Investigating the Effect of Treatment With Dapagliflozin 10mg od on Left Ventricular Distensibility in Patients With Early HFpEF. |
Unknown status |
NCT04475042 |
Phase 2 |
Dapagliflozin;Placebo |
30 |
A Pilot Study Of ALT-711 In Elderly Patients With Isolated Diastolic Heart Failure: The DIAMOND Study |
Completed |
NCT00043836 |
Phase 2 |
ALT-711 |
31 |
A Study of the Acute Hemodynamic and Myocardial Effects of Nesiritide in Diastolic Heart Failure. |
Completed |
NCT00309868 |
Phase 1, Phase 2 |
neseritide |
32 |
A Phase 2 Randomised, Double-Blind, Placebo-Controlled Exploratory Efficacy Study Of Sitaxsentan Sodium To Improve Impaired Exercise Tolerance In Subjects With Diastolic Heart Failure |
Completed |
NCT00303498 |
Phase 2 |
Sitaxsentan sodium;Placebo |
33 |
Randomised Double Blind Placebo Controlled Trial of Perhexiline in Heart Failure With Preserved Ejection Fraction Syndrome (HFpEF) |
Completed |
NCT00839228 |
Phase 2 |
Perhexiline;Placebo |
34 |
Evaluation of Efficacy and Safety of Metoprolol XR in Patients Having Heart Failure With Normal Ejection Fraction: A Randomised, Double Blind,Placebo Controlled Trial |
Completed |
NCT03882710 |
Phase 2 |
Metoprolol XR |
35 |
Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF |
Completed |
NCT02256345 |
Phase 2 |
KNO3;KCl |
36 |
A Randomized, Double-blind, Placebo-controlled Study of Ranolazine in Patients With Heart Failure With Preserved Ejection Fraction |
Completed |
NCT01163734 |
Phase 2 |
Ranolazine |
37 |
Reducing Symptom Burden in Patients With Heart Failure With Preserved Ejection Fraction Using Ubiquinol and/or D-ribose |
Completed |
NCT03133793 |
Phase 2 |
CoQ10;D-Ribose Oral Powder |
38 |
Radiofrequency-based Speckle Tracking Echocardiography to Evaluate Diastolic Function |
Completed |
NCT01182805 |
Phase 1, Phase 2 |
|
39 |
A Dose Escalation Study to Evaluate the Effect of Inhaled Nitrite on Cardiopulmonary Hemodynamics in Subjects With Pulmonary Hypertension |
Completed |
NCT01431313 |
Phase 2 |
Inhaled Nitrite |
40 |
Prevention of Age-associated Cardiac and Vascular Dysfunction Through Nrf2 Signaling Using the Nutritional Supplement Sulforaphane |
Recruiting |
NCT05408559 |
Phase 1, Phase 2 |
Sulforaphane |
41 |
Regress-HFPEF: Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFPEF Patients Treated With Allogeneic CDCs |
Active, not recruiting |
NCT02941705 |
Phase 2 |
|
42 |
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure |
Terminated |
NCT00662116 |
Phase 2 |
alagebrium;placebo |
43 |
A Randomized Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure |
Terminated |
NCT01913301 |
Phase 2 |
Alagebrium |
44 |
Acute Hemodynamic Effects of Riociguat (BAY63-2521) in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure: A Randomized, Double-blind, Placebo-controlled, Single-dose Study in Three Ascending Dose Cohorts |
Terminated |
NCT01172756 |
Phase 2 |
Riociguat (BAY63-2521);Placebo |
45 |
If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure |
Withdrawn |
NCT00757055 |
Phase 2 |
Ivabradine;Placebo |
46 |
GRAPe Seed Extract and Ventriculovascular Investigation in Normal Ejection-Fraction Heart Failure |
Completed |
NCT01185067 |
Phase 1 |
grape seed extract (MegaNatural BP, Polyphenolics, Inc.) |
47 |
Phase 1 Open Label, Dose Escalation Trial of Intracoronary Infusion of NAN-101 in Subjects With NYHA Class III Heart Failure |
Recruiting |
NCT04179643 |
Phase 1 |
|
48 |
Diastolic Heart Failure Management by Nifedipine |
Unknown status |
NCT01157481 |
|
Conventional therapy plus nifedipine;Conventional therapy |
49 |
Markers of Oxidative Stress Present in Blood in Patients With Diastolic Dysfunction |
Unknown status |
NCT00846404 |
|
|
50 |
Effect of Pedometer-Based Walking Intervention on Functional Capacity and Neurohumoral Modulation in Patients With Chronic Heart Failure With Preserved Ejection Fraction: a Multicenter Randomized Controlled Trial |
Unknown status |
NCT03041376 |
|
|
|